International Clinical Trial: Preliminary Phase II Clinical Study Protocol for Preoperative Neoadjuvant Hepatic Arterial Infusion Chemotherapy Combined with Hepatic Arterial Embolization Chemotherapy and Targeted Immunotherapy to Prolong Survival in Patients with Hepatocellular Carcinoma at High Risk of Postoperative Recurrence and Metastasis

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119366) titled 'Preliminary Phase II Clinical Study Protocol for Preoperative Neoadjuvant Hepatic Arterial Infusion Chemotherapy Combined with Hepatic Arterial Embolization Chemotherapy and Targeted Immunotherapy to Prolong Survival in Patients with Hepatocellular Carcinoma at High Risk of Postoperative Recurrence and Metastasis' on Feb. 26.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences)

Condition: Following collective deliberation by the hepatobiliary surgery expert panel, it is determined that patients with CNLC stag...